Virtual Conference
Heart 2022 Conference

Simon Wolfgang Schulz-Falten

University of Medicine, Pharmacy, Science and Technology Targu-Mures, Germany

Title: Heart failure in a young male patient with dilated cardiomyopathy

Abstract

A 41-year-old Caucasian male with no documented history of chronic disease was treated by his family physician for repeated episodes of intermittent dyspnea and cough since 2011. In July 2018 he was referred by the pneumologist for a cardiovascular checkup. The patient is a former heavy smoker with moderate alcohol consumption and no family history of cardiovascular disease. After careful diagnostic strategy and accurate management, dilated cardiomyopathy of non-ischemic etiology possibly post-myocarditis, HFrEF NYHA functional class II and type 2 diabetes mellitus were diagnosed. According to guidelines, optimal drug therapy was initiated. Following repeated episodes of non-sustained ventricular tachycardia an ICD system was implanted. Between September 2018 and May 2021, the patient had repeated (eleven) heart failure hospitalizations and severely unstable heart failure biomarkers. Following initiation of heart failure treatment respecting the 2021 guidelines, between October 2021 to March 2022 the patient had a remarkably low number of planned heart failure hospitalizations (two). A significant decrease in NT-proBNP was also noted. Non-invasive and invasive diagnostic methods reliably identified a non-ischemic cardiomyopathy as the cause of HFrEF in a young male presenting with few typical symptoms and less specific signs of heart failure. Possible etiologies of the dilated cardiomyopathy, such as toxic, immune-mediated and inflammatory damage, or idiopathic/genetic are still in debate. Long-term follow-up necessitates a multidisciplinary team of general practitioner, clinical cardiologist, electrophysiologist and diabetologist. Patient centered optimal medical therapy according to the best available evidence support the heart failure guidelines’ “key message” of a multi-disciplinary HF management plan as recommendation for heart failure patients. 

Biography

Simon Wolfgang Schulz-Falten is a 4th year medical student at the University of Medicine Pharmacy, Science and Technology of Targu-Mures, Romania